
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401

Balance Sheet
Balance Sheet Decomposition
Zhejiang Garden Bio-chemical High-tech Co Ltd
Current Assets | 2.5B |
Cash & Short-Term Investments | 1.4B |
Receivables | 192.3m |
Other Current Assets | 869.5m |
Non-Current Assets | 3.1B |
Long-Term Investments | 64.5m |
PP&E | 2.8B |
Intangibles | 209.2m |
Other Non-Current Assets | 36.3m |
Balance Sheet
Zhejiang Garden Bio-chemical High-tech Co Ltd
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
72
|
58
|
441
|
185
|
506
|
1 159
|
473
|
524
|
1 383
|
1 267
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
473
|
524
|
1 383
|
1 267
|
|
Cash Equivalents |
72
|
58
|
441
|
185
|
506
|
1 159
|
0
|
0
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
100
|
200
|
0
|
0
|
0
|
140
|
|
Total Receivables |
38
|
99
|
73
|
120
|
96
|
104
|
144
|
228
|
119
|
192
|
|
Accounts Receivables |
25
|
90
|
65
|
100
|
63
|
64
|
88
|
169
|
93
|
156
|
|
Other Receivables |
13
|
9
|
8
|
20
|
33
|
40
|
55
|
59
|
27
|
37
|
|
Inventory |
177
|
165
|
203
|
252
|
307
|
307
|
430
|
546
|
780
|
838
|
|
Other Current Assets |
10
|
57
|
152
|
411
|
4
|
2
|
64
|
89
|
179
|
31
|
|
Total Current Assets |
298
|
379
|
869
|
968
|
1 013
|
1 772
|
1 111
|
1 387
|
2 462
|
2 469
|
|
PP&E Net |
429
|
432
|
430
|
471
|
859
|
1 447
|
2 165
|
2 460
|
2 489
|
2 833
|
|
PP&E Gross |
429
|
432
|
430
|
471
|
859
|
1 447
|
2 165
|
2 460
|
2 489
|
2 833
|
|
Accumulated Depreciation |
81
|
44
|
137
|
169
|
200
|
233
|
212
|
265
|
365
|
496
|
|
Intangible Assets |
57
|
62
|
93
|
168
|
171
|
171
|
182
|
191
|
197
|
209
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
2
|
0
|
0
|
31
|
30
|
30
|
51
|
68
|
66
|
64
|
|
Other Long-Term Assets |
2
|
3
|
3
|
9
|
6
|
6
|
21
|
26
|
46
|
36
|
|
Total Assets |
788
N/A
|
877
+11%
|
1 395
+59%
|
1 646
+18%
|
2 080
+26%
|
3 425
+65%
|
3 530
+3%
|
4 132
+17%
|
5 261
+27%
|
5 613
+7%
|
|
Liabilities | |||||||||||
Accounts Payable |
59
|
50
|
34
|
39
|
39
|
145
|
320
|
423
|
307
|
324
|
|
Accrued Liabilities |
5
|
8
|
14
|
15
|
20
|
32
|
45
|
70
|
53
|
66
|
|
Short-Term Debt |
0
|
52
|
45
|
0
|
255
|
200
|
423
|
550
|
428
|
479
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
255
|
198
|
|
Other Current Liabilities |
6
|
10
|
16
|
28
|
20
|
27
|
110
|
266
|
220
|
208
|
|
Total Current Liabilities |
70
|
119
|
109
|
82
|
333
|
405
|
898
|
1 309
|
1 264
|
1 275
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
923
|
1 054
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
35
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
6
|
5
|
4
|
3
|
4
|
111
|
349
|
250
|
136
|
30
|
|
Total Liabilities |
76
N/A
|
124
+64%
|
114
-8%
|
85
-26%
|
337
+298%
|
515
+53%
|
1 247
+142%
|
1 560
+25%
|
2 367
+52%
|
2 394
+1%
|
|
Equity | |||||||||||
Common Stock |
181
|
181
|
192
|
479
|
479
|
551
|
551
|
551
|
551
|
543
|
|
Retained Earnings |
480
|
521
|
642
|
923
|
1 204
|
1 477
|
1 830
|
2 111
|
2 226
|
2 497
|
|
Additional Paid In Capital |
51
|
51
|
447
|
159
|
159
|
982
|
2
|
36
|
8
|
54
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
100
|
100
|
100
|
54
|
140
|
27
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
264
|
258
|
|
Total Equity |
712
N/A
|
753
+6%
|
1 281
+70%
|
1 562
+22%
|
1 743
+12%
|
2 910
+67%
|
2 283
-22%
|
2 572
+13%
|
2 893
+12%
|
3 218
+11%
|
|
Total Liabilities & Equity |
788
N/A
|
877
+11%
|
1 395
+59%
|
1 646
+18%
|
2 080
+26%
|
3 425
+65%
|
3 530
+3%
|
4 132
+17%
|
5 261
+27%
|
5 613
+7%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
454
|
454
|
479
|
479
|
472
|
543
|
543
|
543
|
535
|
543
|